A carregar...
Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation
OBJECTIVES: No randomized controlled trials have yet reported an individual patient benefit of initiating combination antiretroviral therapy (cART) at CD4 counts > 350 cells/μL. It is hypothesized that earlier initiation of cART in asymptomatic and otherwise healthy individuals may lead to poorer...
Na minha lista:
Publicado no: | HIV Med |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4949527/ https://ncbi.nlm.nih.gov/pubmed/26306942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12302 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|